Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 21, 2017; 23(47): 8355-8366
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8355
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8355
Figure 3 Effect of rifaximin on cognitive disturbance.
Comparison of the mean time required for NCT between baseline and 4 wk post-rifaximin among (A) total patients (n =20) and (B) the patients who showed prolongation for NCT (> 50 s) at baseline (n = 10). Data are means ± SD.
- Citation: Kaji K, Takaya H, Saikawa S, Furukawa M, Sato S, Kawaratani H, Kitade M, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. World J Gastroenterol 2017; 23(47): 8355-8366
- URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8355.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8355